CLPT
NASD ClearPoint Neuro, Inc.$9.81 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.81, $0.36 below the day’s high of $10.17
- YTD change
- -28.29%
- vs 20-day SMA
- -22.84%
- vs 200-day SMA
- -26.29%
Price ranges
Price & Performance
-0.20 (-2.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 68.6% away from all-time highs of $31.29
- CLPT is down 28% since the beginning of the year
- CLPT is down 63% over the past 12 months
- CLPT is down 27% over the past 1 month
- 17% of all CLPT investors are betting against CLPT
CLPT reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -62.7%.
- Previous minute
- +$0.00
- Last hour
- -$0.14
- Last 5 days
- -14.84%
- vs 8-day SMA
- -9.49%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
ClearPoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.